Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid β in rabbit brain

Journal of Molecular Neuroscience

Volumn 24, Issue 1, 2004, Pages 97-104

  Sparks, D Larry ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's pathology; Amyloid; Cholesterol; Copper; Water quality

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; COPPER; THIOFLAVINE; THIAZOLE DERIVATIVE;

ADOLESCENT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN; BRAIN BLOOD VESSEL; CHOLESTEROL INTAKE; CONFERENCE PAPER; IMMUNOREACTIVITY; MALE; MEMORY DISORDER; NERVE CELL; NEW ZEALAND; NONHUMAN; RABBIT; ANIMAL; ARTICLE; BLOOD VESSEL; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; ELEMENTAL DIET; IMMUNOHISTOCHEMISTRY; METABOLIC CLEARANCE RATE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALIA; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BLOOD VESSELS; BRAIN; CHOLESTEROL; COPPER; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FOOD, FORMULATED; IMMUNOHISTOCHEMISTRY; MALE; METABOLIC CLEARANCE RATE; NEURONS; RABBITS; THIAZOLES; UP-REGULATION;

EID: 16544362951     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Atwood C. S., Scarpa R. C., Huang X., Moiré R. D., Jones W. D., Fairly D. P., et al. (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides: Identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75, 1219-1233.
2. Austen B. M., Frears E. R., and Davies H. (2000) Cholesterol upregulates production of Abeta 1-40 and 1-42 in transfected cells. Neurobiol. Aging 21, S254.
3. Austen B. M., Sidera C., Liu C., and Frears E. (2003) The role of intracellular cholesterol on the processing of the B-amyloid precursor protein. J. Nutr. Health Aging 7, 31-36.
4. Bales K. R., Fishman C., DeLong C., Du Y., Jordan W., and Paul S. M. (2000) Diet-induced hyperlipidemia accelerates amyloid deposition in the APPv717f transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 21, S139.
5. Bergmann C., Runz H., Jakala P., and Hartmann T. (2000) Diversification of gamma-secretase versus beta-secretase inhibition by cholesterol depletion. Neurobiol. Aging 21, S278.
6. Beyreuther K. (2000) Physiological function of APP processing. Neurobiol. Aging 21, S69.
7. Bush A. I., Multhaup G., Moir R. D., Williamson T. G., Small D. H., Rumble B., et al. (1993) A novel zinc (II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268, 16109-16112.
8. Bush A. I., Pettingell W. H., Jr., Paradis M. D., and Tanzi R. E. (1994) Modulation of A beta adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269, 12152-12158.
9. Chen M., Durr J., and Fernandez H. L. (2000) Possible role of calpain in normal processing of beta-amyloid precursor protein in human platelets. Biochem. Biophys. Res. Commun. 273, 170-175.
10. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A., et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
11. Cornett C. R., Markesbery W. R., and Ehmann W. D. (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339-345.
12. Cuajungco M. P., Goldstein L. E., Nunomura A., Smith M. A., Lim J. T., Atwood C. S., et al. (2000) Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J. Biol. Chem. 275, 19439-19442.
13. DeMattos R. B., Bales K. R., Cummins D. J., Dodart J. C., Paul S. M., and Holtzman D. M. (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98, 8850-8855.
14. DeMattos R. B., Bales K. R., Cummins D. J., Paul S. M., and Holtzman D. M. (2002a) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264-2267.
15. DeMattos R. B., Bales K. R., Parsadanian M., O'Dell M. A., Foss E. M., Paul S. M., and Holtzman D. M. (2002b) Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J. Neurochem. 81, 229-236.
16. Durham R. A., Parker C. A., Emmerling M. R., Bisgaier C. L., and Walker L. C. (1998) Effect of age and diet on the expression of beta-amyloid 1-40 and 1-42 in the brains of apolipoprotein-E-deficient mice. Neurobiol. Aging 19, S281.
17. Fassbender K., Simons M., Bergmann C., Stroick M., Jutojohann D., Keller P., et al. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98, 5371-5373.
18. Finefrock A. E., Bush A. I., and Doraiswarny P. M. (2003) Current status of metals as therapeutic targets in Alzheimer's disease. J. Am. Geriatr. Soc. 51, 1143-1148.
19. Frears E. R., Stephens D. J., Walters C. E., Davies H., and Austen B. M. (1999) The role of cholesterol in the biosynthesis of β-amyloid. NeuroReport 10, 1699-1705.
20. Fung Y. K., Meade A. G., Rack E. P., Blotcky A. J., Claassen J. P., Beatty M. W., and Durham T. (1996) Mercury determination in nursing home patients with Alzheimer's disease. Gen. Dent. 44, 74-78.
21. Galbete J. L., Martin T. R., Peressini E., Modena P., Bianchi R., and Forloni G. (2000) Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. Biochem. J. 348, 307-313.
22. Huang X., Cuajungco M. P., Atwood C. S., Moir R. D., Tanzi R. E., and Bush A. I. (2000) Alzheimer's disease, beta-amyloid protein and zinc. J. Nutr. 130, 1488S-1492S.
23. Li L., Zeigler S., Lindsey R. J., and Fukuchi K. (1999) Effects of an atherogenic diet on amyloidosis in transgenic mice overexpressing the C-terminal portion of b-amyloid precurson protein. Soc. Neurosci. 25, 1859.
24. Moir R. D., Atwood C. S., Romano D. M., Laurans M. H., Huang X., Bush A. I., et al. (1999) Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations. Biochemistry 38, 4595-4603.
25. Molina J. A., Jimenez-Jimenez F. J., Aguilar M. V., Mesenguer I., Mateos-Vega C. J., Conzalez-Munoz M. J., et al. (1998) Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J. Neural Transm. 105, 479-488.
26. Racchi M., Baetta R., Salvietti N., Ianna P., Franceschini G., Paoletti R., et al. (1997) Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J. 322, 893-898.
27. Refolo L. M., Pappolla M. A., LaFrancois J., Malester B., Schmidt S. D., Thomas-Bryant T., et al. (2001) A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 5, 890-899.
28. Refolo L. M., Pappolla M. A., Malester B., LaFrancois J., Bryant-Thomas Wang R., et al. (2000) Hypercholesterolemia accelerates Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321-331.
29. Regland B., Lehmann W., Abedini I., Blennow K., Jonsson M., Karlsson I., et al. (2001) Treatment of Alzheimer's disease with Clioquinol. Dement. Geriatr. Cogn. Disord. 12, 408-414.
30. Robinson S. R. and Bishop G. M. (2002) Ab as a bioflocculant: Implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol. Aging 23, 1051-1072.
31. Schreurs B. G., Smith-Bell C. A., Lochhead J., and Sparks D. L. (2003) Cholesterol modifies classical conditioning of the rabbit nictitating membrane response. Behav. Neurosci. 117, 1220-1232.
32. Shie F.- G., Jin L.- W., Cook D. G., Leverenz J. B., and LeBoeul R. C. (2002) Diet-induced hypercholesterolemia enhances brain Ab accumulation in transgenic mice. NeuroReport 13, 455-459.
33. Simons M,. Keller P., De Strooper B., Beyreuther K., Dotti C. G., and Simons K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 6460-6464.
34. Sparks D. L. (1996) Intraneuronal β-amyloid immunoreactivity in the CNS. Neurobiol. Aging 17, 291-299.
35. Sparks D. L. (1997) Dietary cholesterol induces Alzheimer-like β-amyloid immunoreactivity in rabbit brain. Nutr. Metab. Cardiovasc. Dis. 7, 255-266.
36. Sparks D. L. (1999) Neuropathologic links between Alzheimer's disease and vascular disease, in Alzheimer's Disease and Related Disorders, Iqbal K., Swaab D. F., Winblad B., Wisniewski H. M., eds., John Wiley Chichester, West Sussex, England, pp. 153-163.
37. Sparks D. L. and Schreurs B. G. (2003) Trace amounts of copper in water induce b-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 100, 1065-1069.
38. Sparks D. L., Kou Y.- M., Roher A., Martin T. A., and Lukas R. J. (2000) Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann. N. Y. Acad. Sci. 903, 335-344.
39. Sparks D. L., Liu H., Gross D. R., and Scheff S. W. (1995) Increased density of cortical Apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol. Neurosci. Lett. 187, 142-144.
40. Sparks D. L., Lochhead J., Horstman D., Wagoner T., and Martin T. (2002) Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid b (Ab) in rabbit brain. J. Alzheimer Dis. 4, 523-529.
41. Sparks D. L., Scheff S. W., Hunsaker J. C. III, Liu H., Landers T., and Gross D. R. (1994) Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88-94.
42. Squitti R., Rossini P. M., Cassetta E., Moffa F., Pasqualetti P., Cortesi M., et al. (2002) D-penicillamine reduces serum oxidative stress in Alzheimer's disease patients. Eur. J. Clin. Invest. 32, 51-59.
43. Streit W. J. and Sparks D. L. (1997) Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J. Mol. Med. 75, 130-138.
44. White A. R., Reyes R., Mercer J. F., Camakaris J., Zheng H., Bush A. I., et al. (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 842, 439-444.